Illinois General Assembly - Bill Status for SB2893
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

 Bill Status of SB2893  103rd General Assembly


Senate Sponsors
Sen. Karina Villa - Robert Peters - Lakesia Collins, Mary Edly-Allen, Javier L. Cervantes, Michael W. Halpin, Ram Villivalam, Natalie Toro, Rachel Ventura and Paul Faraci

Last Action
DateChamber Action
  3/15/2024SenateRule 3-9(a) / Re-referred to Assignments

Statutes Amended In Order of Appearance
New Act

Synopsis As Introduced
Creates the Wholesale Prescription Drug Importation Program Act. Requires the Department of Public Health to establish the Wholesale Prescription Drug Importation Program. Provides that the Department shall implement the program by: (1) contracting with one or more prescription drug wholesalers and Canadian suppliers to import prescription drugs and provide prescription drug cost savings to consumers in this State; (2) developing a registration process for health benefit plan issuers, health care providers, and pharmacies to obtain and dispense prescription drugs imported under the program; (3) developing a list of prescription drugs, including the prices of those drugs, that meet certain requirements set forth under the Act and publishing the list on the Department's website; (4) establishing an outreach and marketing plan to generate program awareness; (5) ensuring the program and the prescription drug wholesalers that contract with this State comply with certain federal tracking, tracing, verification, and identification requirements; and other matters. Sets forth eligibility criteria for prescription drugs that may be imported into the State under the program. Contains provisions concerning anticompetitive behavior monitoring; program funding; audit procedures; annual reporting requirements; the adoption of rules to implement the Act; and federal waiver or authorization requirements. Effective July 1, 2024.

DateChamber Action
  1/24/2024SenateFiled with Secretary by Sen. Karina Villa
  1/24/2024SenateFirst Reading
  1/24/2024SenateReferred to Assignments
  2/6/2024SenateDirected to Multiple Committees Public Health; Appropriations
  2/6/2024SenateAssigned to Public Health
  2/6/2024SenateAdded as Co-Sponsor Sen. Mary Edly-Allen
  2/6/2024SenateAdded as Co-Sponsor Sen. Javier L. Cervantes
  2/7/2024SenateAdded as Co-Sponsor Sen. Michael W. Halpin
  2/7/2024SenateAdded as Co-Sponsor Sen. Ram Villivalam
  2/7/2024SenateAdded as Co-Sponsor Sen. Natalie Toro
  2/7/2024SenateAdded as Chief Co-Sponsor Sen. Robert Peters
  2/7/2024SenateAdded as Chief Co-Sponsor Sen. Lakesia Collins
  2/8/2024SenateAdded as Co-Sponsor Sen. Rachel Ventura
  2/21/2024SenatePostponed - Public Health
  2/21/2024SenateAdded as Co-Sponsor Sen. Paul Faraci
  2/22/2024SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Karina Villa
  2/22/2024SenateSenate Committee Amendment No. 1 Referred to Assignments
  2/28/2024SenateSenate Committee Amendment No. 1 Pursuant to Senate Rule 3-8(b-1), the following amendment will remain in the Committee on Assignments.
  3/15/2024SenateRule 3-9(a) / Re-referred to Assignments

Back To Top